Volume 7, Issue 26 (4-2017)                   NCMBJ 2017, 7(26): 43-58 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Azmoodeh S, Izadyar M, Shokooh Saljooghi A, babaee M. Anti-proliferative and Apoptotic Effects of Nickel Complexes including 3-Hydroxyflavone, 3-Hydroxy-2-methyl-4-pyrone (Maltol) and 3-Hydroxy-1,2-dimethyl-4-pyridinone (Deferiprone) on some Cancer Cell Lines. NCMBJ 2017; 7 (26) :43-58
URL: http://ncmbjpiau.ir/article-1-950-en.html
Department of Chemistry, University of Mashhad, Mashhad, Iran , saljooghi@um.ac.ir
Abstract:   (8200 Views)
Aim and Background: Studies demonstrated that some ligands such as maltol in coordination with metals, induce apoptosis and inhibit the cancer cells proliferation. The aim of this study is the synthesis of new complexes of nickel and evaluation of anti-proliferative and apoptotic effects of these compounds. Material and methods: In this study, we synthesized the novel complexes of nickel with maltol, deferiprone and 3-hydroxyflavone ligands. The cytotoxicity of this complex was screened for antitumor activity against HeLa, MCF-7, MDA-MB-231, NALM-6, Neuro-2a and L929 by MTT assay and Flow cytometry. Results: The IC50 ± SD (μM) values, calculated for synthesized complex against HeLa, MCF-7, MDA-MB-231, NALM-6, Neuro-2a and L929 cell lines are between 15.6 to 199.1, 5.00 to 185.2 and 39.8 to 168.8 for complexes 1 to 3 respectively. Conclusion: Our results showed that investigated complex exhibited higher cytotoxic activities against MDA-MB-231 and Neuro-2a compared to other cell lines. Our results confirmed that the synthesized compound have not any cytotoxicity effects on mouse fibroblast cell line (L929).
Full-Text [PDF 1045 kb]   (3538 Downloads)    
Type of Study: Research Article | Subject: Genetics
Received: 2017/06/11 | Accepted: 2017/06/11 | Published: 2017/06/11

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | New Cellular and Molecular Biotechnology Journal

Designed & Developed by : Yektaweb